Sign In
Buy IHE
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:31am, Monday, 11'th Dec 2023
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fun
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
08:01am, Wednesday, 22'nd Nov 2023
A new ETF hit the market Tuesday, creating buzz for its exposure to popular weight-loss drugs, while expanding the roster of thematic ETFs available for investors willing to pay up for stock-picking p
Pharma ETFs in Focus Post Q3 Earnings
12:46pm, Wednesday, 08'th Nov 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Eli Lilly Beats on Q3 Earnings: ETFs to Buy
12:47pm, Friday, 03'rd Nov 2023
Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:31am, Tuesday, 10'th Oct 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/200
IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long Run
06:18am, Monday, 21'st Aug 2023
iShares U.S. Pharmaceuticals ETF invests almost 80 percent of its assets in its top 10 holdings, and 48.5 percent in just two companies: JNJ and LLY. IHE didn't generate strong or decent yield, but pr
Pharma ETF (IHE) Hit a 52-Week High
08:40am, Tuesday, 15'th Aug 2023
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
6 Best-Performing ETFs of Last Week
01:09pm, Monday, 14'th Aug 2023
Wall Street delivered a mixed performance last week.
3 Sector ETFs That Beat The Market Last Week
12:24pm, Monday, 14'th Aug 2023
Wall Street wrapped up the last week with mixed performances. The pharma and energy sectors were the biggest winners last week.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:45am, Thursday, 10'th Aug 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/200
Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap
11:27am, Wednesday, 09'th Aug 2023
Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs ha
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:34am, Monday, 22'nd May 2023
Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity mar
Pharma ETFs Gain Post Q1 Earnings
01:01pm, Tuesday, 09'th May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
IHE: Pharmaceutical Stocks Are Cheap And Offer High Long-Term Returns
12:03am, Tuesday, 02'nd May 2023
IHE invests in U.S. pharmaceutical stocks. Based on consensus forward earnings growth estimates, IHE looks undervalued.
